Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials - PubMed (original) (raw)
Review
doi: 10.1136/bmj.f1325.
Affiliations
- PMID: 23558162
- DOI: 10.1136/bmj.f1325
Free article
Review
Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials
Feng J He et al. BMJ. 2013.
Free article
Abstract
Objective: To determine the effects of longer term modest salt reduction on blood pressure, hormones, and lipids.
Design: Systematic review and meta-analysis.
Data sources: Medline, Embase, Cochrane Hypertension Group Specialised Register, Cochrane Central Register of Controlled Trials, and reference list of relevant articles.
Inclusion criteria: Randomised trials with a modest reduction in salt intake and duration of at least four weeks.
Data extraction and analysis: Data were extracted independently by two reviewers. Random effects meta-analyses, subgroup analyses, and meta-regression were performed.
Results: Thirty four trials (3230 participants) were included. Meta-analysis showed that the mean change in urinary sodium (reduced salt v usual salt) was -75 mmol/24 h (equivalent to a reduction of 4.4 g/day salt), and with this reduction in salt intake, the mean change in blood pressure was -4.18 mm Hg (95% confidence interval -5.18 to -3.18, I(2)=75%) for systolic blood pressure and -2.06 mm Hg (-2.67 to -1.45, I(2)=68%) for diastolic blood pressure. Meta-regression showed that age, ethnic group, blood pressure status (hypertensive or normotensive), and the change in 24 hour urinary sodium were all significantly associated with the fall in systolic blood pressure, explaining 68% of the variance between studies. A 100 mmol reduction in 24 hour urinary sodium (6 g/day salt) was associated with a fall in systolic blood pressure of 5.8 mm Hg (2.5 to 9.2, P=0.001) after adjustment for age, ethnic group, and blood pressure status. For diastolic blood pressure, age, ethnic group, blood pressure status, and the change in 24 hour urinary sodium explained 41% of the variance between studies. Meta-analysis by subgroup showed that in people with hypertension the mean effect was -5.39 mm Hg (-6.62 to -4.15, I(2)=61%) for systolic blood pressure and -2.82 mm Hg (-3.54 to -2.11, I(2)=52%) for diastolic blood pressure. In normotensive people, the figures were -2.42 mm Hg (-3.56 to -1.29, I(2)=66%) and -1.00 mm Hg (-1.85 to -0.15, I(2)=66%), respectively. Further subgroup analysis showed that the decrease in systolic blood pressure was significant in both white and black people and in men and women. Meta-analysis of data on hormones and lipids showed that the mean change was 0.26 ng/mL/h (0.17 to 0.36, I(2)=70%) for plasma renin activity, 73.20 pmol/L (44.92 to 101.48, I(2)=62%) for aldosterone, 187 pmol/L (39 to 336, I(2)=5%) for noradrenaline (norepinephrine), 37 pmol/L (-1 to 74, I(2)=12%) for adrenaline (epinephrine), 0.05 mmol/L (-0.02 to 0.11, I(2)=0%) for total cholesterol, 0.05 mmol/L (-0.01 to 0.12, I(2)=0%) for low density lipoprotein cholesterol, -0.02 mmol/L (-0.06 to 0.01, I(2)=16%) for high density lipoprotein cholesterol, and 0.04 mmol/L (-0.02 to 0.09, I(2)=0%) for triglycerides.
Conclusions: A modest reduction in salt intake for four or more weeks causes significant and, from a population viewpoint, important falls in blood pressure in both hypertensive and normotensive individuals, irrespective of sex and ethnic group. Salt reduction is associated with a small physiological increase in plasma renin activity, aldosterone, and noradrenaline and no significant change in lipid concentrations. These results support a reduction in population salt intake, which will lower population blood pressure and thereby reduce cardiovascular disease. The observed significant association between the reduction in 24 hour urinary sodium and the fall in systolic blood pressure, indicates that larger reductions in salt intake will lead to larger falls in systolic blood pressure. The current recommendations to reduce salt intake from 9-12 to 5-6 g/day will have a major effect on blood pressure, but a further reduction to 3 g/day will have a greater effect and should become the long term target for population salt intake.
Comment in
- Public health: Effects of sodium and potassium intake on health outcomes.
Chang A, Appel LJ. Chang A, et al. Nat Rev Nephrol. 2013 Jul;9(7):376-7. doi: 10.1038/nrneph.2013.107. Epub 2013 Jun 11. Nat Rev Nephrol. 2013. PMID: 23752886 No abstract available.
Similar articles
- Effect of longer-term modest salt reduction on blood pressure.
He FJ, Li J, Macgregor GA. He FJ, et al. Cochrane Database Syst Rev. 2013 Apr 30;2013(4):CD004937. doi: 10.1002/14651858.CD004937.pub2. Cochrane Database Syst Rev. 2013. PMID: 23633321 Free PMC article. Review. - Effect of longer-term modest salt reduction on blood pressure.
He FJ, MacGregor GA. He FJ, et al. Cochrane Database Syst Rev. 2004;(3):CD004937. doi: 10.1002/14651858.CD004937. Cochrane Database Syst Rev. 2004. PMID: 15266549 Updated. Review. - Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride.
Graudal NA, Hubeck-Graudal T, Jurgens G. Graudal NA, et al. Cochrane Database Syst Rev. 2017 Apr 9;4(4):CD004022. doi: 10.1002/14651858.CD004022.pub4. Cochrane Database Syst Rev. 2017. PMID: 28391629 Free PMC article. Updated. Review. - Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health.
He FJ, MacGregor GA. He FJ, et al. J Hum Hypertens. 2002 Nov;16(11):761-70. doi: 10.1038/sj.jhh.1001459. J Hum Hypertens. 2002. PMID: 12444537 - Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials.
Huang L, Trieu K, Yoshimura S, Neal B, Woodward M, Campbell NRC, Li Q, Lackland DT, Leung AA, Anderson CAM, MacGregor GA, He FJ. Huang L, et al. BMJ. 2020 Feb 24;368:m315. doi: 10.1136/bmj.m315. BMJ. 2020. PMID: 32094151 Free PMC article.
Cited by
- Effect of a Low Salt Diet on the Progression of Chronic Kidney Disease: A Prospective, Open-Label, Randomized Controlled Trial.
Trakarnvanich T, Chailimpamontree W, Kantachuvesiri S, Anutrakulchai S, Manomaipiboon B, Ngamvitchukorn T, Suraamornkul S, Trakarnvanich T, Kurathong S. Trakarnvanich T, et al. J Prim Care Community Health. 2024 Jan-Dec;15:21501319241297766. doi: 10.1177/21501319241297766. J Prim Care Community Health. 2024. PMID: 39526855 Free PMC article. Clinical Trial. - Inside CKD: a microsimulation modelling study projects the clinical and economic burden of chronic kidney disease in Hungary.
Szabó L, Halmai LA, Ladányi E, Garcia Sanchez JJ, Barone S, Cabrera C, Retat L, Webber L, Wittmann I, Laczy B. Szabó L, et al. Front Nephrol. 2024 Oct 18;4:1458607. doi: 10.3389/fneph.2024.1458607. eCollection 2024. Front Nephrol. 2024. PMID: 39493371 Free PMC article. - Night-time hot spring bathing is associated with improved blood pressure control: A mobile application and paper questionnaire study.
Yamasaki S, Kashiwado Y, Maeda T, Horiuchi T. Yamasaki S, et al. PLoS One. 2024 Nov 1;19(11):e0299023. doi: 10.1371/journal.pone.0299023. eCollection 2024. PLoS One. 2024. PMID: 39485773 Free PMC article. - Assessing Knowledge, Attitudes and Behaviours toward Salt and Sugar Consumption in the Central Division of Fiji.
Waqa G, Bell C, Santos JA, Rogers K, Silatolu AM, Reeve E, Palu A, Deo A, Webster J, McKenzie B. Waqa G, et al. Nutrients. 2024 Sep 28;16(19):3288. doi: 10.3390/nu16193288. Nutrients. 2024. PMID: 39408255 Free PMC article. - Microbiota and probiotics: chances and challenges - a symposium report.
Ruxton CHS, Kajita C, Rocca P, Pot B. Ruxton CHS, et al. Gut Microbiome (Camb). 2023 Mar 27;4:e6. doi: 10.1017/gmb.2023.4. eCollection 2023. Gut Microbiome (Camb). 2023. PMID: 39295904 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical